|Monmouth University, BS|
|Rutgers University, MBA|
Mr. Sobieski joined Roka Bioscience in September 2009.
He brings to Roka 20 years of financial management experience in a variety of roles in biotechnology and public accounting. Prior to joining Roka, Mr. Sobieski served from 2000 to 2009 as senior vice president and chief financial officer at LifeCell Corporation, a public company focused on developing and marketing reconstructive surgical products.
Mr. Sobieski was vice president of finance at Osteotech, Inc., a public company focused on orthopedic products, where he also served in other positions, from 1991 to 2000. From 1981 through 1991, Mr. Sobieski was with Coopers & Lybrand, a public accounting firm.
Mr. Sobieski received his BS in business administration from Monmouth University, his MBA degree with a concentration in accounting from Rutgers University, and he is a CPA.
Mr. Sobieski serves as a director and chairman of the audit committee of Insulet Corporation, a public medical device company specializing in insulin infusion systems.